2024 HCPCS Code J0578
Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy
TAGS: release buprenorphine greater therapy extended
| Short Description | Inj brixadi, more than 7 day |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | April 01, 2024 |
| HCPCS Code Added Date | April 01, 2024 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J9144 - Daratumumab, hyaluronidase
- J9145 - Injection, daratumumab 10 mg
- J9150 - Daunorubicin injection
- J9151 - Daunorubicin citrate inj
- J9153 - Inj daunorubicin, cytarabine
- J9155 - Degarelix injection
- J9160 - Denileukin diftitox inj
- J9165 - Diethylstilbestrol injection
- J9171 - Docetaxel injection
- J9172 - Docetaxel (ingenus), 1 mg
- J9173 - Inj., durvalumab, 10 mg
- J9175 - Elliotts b solution per ml
- J9176 - Injection, elotuzumab, 1mg
- J9177 - Inj enfort vedo-ejfv 0.25mg
- J9178 - Inj, epirubicin hcl, 2 mg
- J9179 - Eribulin mesylate injection
- J9181 - Etoposide injection
- J9185 - Fludarabine phosphate inj
- J9190 - Fluorouracil injection
- J9196 - Inj gemcitabine hcl (accord)